Research
Extra-hepatic manifestations of metabolic associated steatotic liver disease
Characterisation of the cardiac and renal complications of MASLD using the UKBB
MASLD and HCC risk
Exploration of impact and causes of reduced HCC surveillance in people with MASLD. The development of a novel risk prediction tool for risk stratification of people with MASLD fibrosis who might benefit from HCC surveillance.
Pathways into care and multimorbidity
1. Development of a community patient-led MASLD pathway in the Knowlsley region focused on patient education and addressing cardiometabolic muiltimorbidity
2. Qualitative research exploring patient preferences for MASLD care to help produce a blue-print for patient centered care
Research grants
Patient preferences for the delivery of the non-alcoholic fatty liver disease clinical pathway: let’s move towards patient-centered care (NAFLD)
THE ACADEMY OF MEDICAL SCIENCES (UK)
April 2023 - November 2024